학술논문
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
Document Type
Article
Author
Kehoe, P.G.; Jarutyte, L.; Coulthard, E.; Turner, N.; Howden, B.; Blair, P.S.; Lane, J.A.; Taylor, J.; Ben-Shlomo, Y.; Wilson, A.; Thai, N.J.; Clegg, S.L.; Malone, I.B.; Barnes, J.; Nielsen, C.; Thomas, D.L.; Fox, N.C.; Sudre, C.H.; Passmore, P.; Mutsaerts, H.-J.; Wilkinson, I.; Harkness, K.; Kuruvilla, T.; McShane, R.; Connelly, P.; Duncan, G.; Calvert, L.; Lawrie, A.; Sheridan, M.; Jackson, E.; Udeze, B.; Pearson, S.; Langheinrich, T.; Wagle, S.; Butchart, J.; Macharouthu, A.; Donaldson, A.; Neil, W.; Pattan, V.; Findlay, D.; Thomas, A.; Barber, R.; Byrne, A.; Dalvi, M.; Negi, R.; McGuinness, B.
Source
In: The Lancet Neurology . (The Lancet Neurology, November 2021, 20(11):895-906)
Subject
Language
English
ISSN
14744465
14744422
14744422